Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAOA | P21397 | 8/20 | 0.69 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.67 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.67 |
| ▸ | MAPT | P10636 | 2/20 | 0.67 |
| ▸ | HPGD | P15428 | 2/20 | 0.67 |
| ▸ | CASP7 | P55210 | 2/20 | 0.67 |
| ▸ | HSD17B10 | Q99714 | 2/20 | 0.67 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.67 |
| ▸ | GLA | P06280 | 1/20 | 0.67 |
| ▸ | PGAM1 | P18669 | 1/20 | 0.67 |
| ▸ | CASP1 | P29466 | 1/20 | 0.67 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.67 |
| ▸ | NPC1 | O15118 | 3/20 | 0.60 |
| ▸ | MEN1 | O00255 | 2/20 | 0.60 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.60 |
| ▸ | GAA | P10253 | 2/20 | 0.59 |
| ▸ | ALPI | P09923 | 1/20 | 0.59 |
| ▸ | PKM | P14618 | 1/20 | 0.59 |
| ▸ | CASP3 | P42574 | 1/20 | 0.59 |
| ▸ | RECQL | P46063 | 1/20 | 0.59 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL31512480 | 1.00 | MAOA (0.69) | MAOAKDM4ECYP3A4MAPTHPGD | |
| SCHEMBL9837311 | 0.86 | MAOA (0.61) | MAOAKDM4ECYP3A4MAPTHPGD | |
| SCHEMBL9836614 | 0.86 | MAOA (0.61) | MAOAKDM4ECYP3A4MAPTHPGD | |
| SCHEMBL9836819 | 0.86 | MAOA (0.61) | MAOAKDM4ECYP3A4MAPTHPGD | |
| SCHEMBL9836945 | 0.86 | LMNA (0.65) | MAOAKDM4ECYP3A4MAPTHPGD | |
| SCHEMBL9837713 | 0.86 | MAOA (0.61) | MAOAKDM4ECYP3A4MAPTHPGD | |
| SCHEMBL2318335 | 0.86 | MAOA (0.66) | MAOAKDM4ECYP3A4MAPTHPGD | |
| SCHEMBL3874960 | 0.84 | AHR (0.59) | MAOAKDM4ECYP3A4MAPTHPGD | |
| SCHEMBL21666688 | 0.84 | MAOA (0.78) | MAOAKDM4ECYP3A4MAPTHPGD | |
| SCHEMBL10453866 | 0.84 | TBK1 (0.68) | MAOAKDM4ECYP3A4MAPTHPGD |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 20 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2509561-B1 | A POROUS, DISSOLVABLE SOLID SUBSTRATE AND SURFACE RESIDENT COATING COMPRISING WATER SENSITIVE ACTIVES | PROCTER & GAMBLE (US) | 2017-08-02 | — | — | EP | claimed |
| US-9198838-B2 | Porous, dissolvable solid substrate and surface resident coating comprising water sensitive actives | THE PROCTER & GAMBLE COMPANY (US) | 2015-12-01 | — | — | US | claimed |
| EP-2509561-A2 | A POROUS, DISSOLVABLE SOLID SUBSTRATE AND SURFACE RESIDENT COATING COMPRISING WATER SENSITIVE ACTIVES | The Procter & Gamble Company (US) | 2012-10-17 | — | — | EP | claimed |
| US-20110195098-A1 | Porous, Dissolvable Solid Substrate and Surface Resident Coating Comprising Water Sensitive Actives | THE PROCTER & GAMBLE COMPANY | 2011-08-11 | — | — | US | claimed |
| WO-2011072002-A2 | A POROUS, DISSOLVABLE SOLID SUBSTRATE AND SURFACE RESIDENT COATING COMPRISING WATER SENSITIVE ACTIVES | THE PROCTER & GAMBLE COMPANY (US) | 2011-06-16 | — | — | WO | claimed |
| WO-2025072721-A1 | COMPOSITIONS | UVAGELESS LLC (US) | 2025-04-03 | — | — | WO | disclosed |
| US-12018232-B2 | Multilayer dissolvable solid article containing solid particles for making the same | THE PROCTER & GAMBLE COMPANY (US) | 2024-06-25 | — | — | US | disclosed |
| EP-2509561-B1 | A POROUS, DISSOLVABLE SOLID SUBSTRATE AND SURFACE RESIDENT COATING COMPRISING WATER SENSITIVE ACTIVES | PROCTER & GAMBLE (US) | 2017-08-02 | — | — | EP | disclosed |
| US-9198838-B2 | Porous, dissolvable solid substrate and surface resident coating comprising water sensitive actives | THE PROCTER & GAMBLE COMPANY (US) | 2015-12-01 | — | — | US | disclosed |
| US-9173826-B2 | Porous, dissolvable solid substrate and surface resident coating comprising a zync pyrithione | THE PROCTER & GAMBLE COMPANY (US) | 2015-11-03 | — | — | US | disclosed |
| EP-2536386-A1 | A POROUS, DISSOLVABLE SOLID SUBSTRATE AND SURFACE RESIDENT COATING COMPRISING A ZYNC PYRITHIONE | The Procter & Gamble Company (US) | 2012-12-26 | — | — | EP | disclosed |
| EP-2509561-A2 | A POROUS, DISSOLVABLE SOLID SUBSTRATE AND SURFACE RESIDENT COATING COMPRISING WATER SENSITIVE ACTIVES | The Procter & Gamble Company (US) | 2012-10-17 | — | — | EP | disclosed |
| EP-2509562-A2 | POROUS, DISSOLVABLE SOLID SUBSTRATE AND SURFACE RESIDENT COATING COMPRISING A SKIN TREATMENT ACTIVE | The Gillette Company (US) | 2012-10-17 | — | — | EP | disclosed |
| WO-2011103152-A1 | A POROUS, DISSOLVABLE SOLID SUBSTRATE AND SURFACE RESIDENT COATING COMPRISING A ZYNC PYRITHIONE | THE PROCTER & GAMBLE COMPANY (US) | 2011-08-25 | — | — | WO | disclosed |
| US-20110200649-A1 | Porous, Dissolvable Solid Substrate And Surface Resident Coating Comprising A Zync Pyrithione | THE PROCTER & GAMBLE COMPANY | 2011-08-18 | — | — | US | disclosed |
| US-20110195098-A1 | Porous, Dissolvable Solid Substrate and Surface Resident Coating Comprising Water Sensitive Actives | THE PROCTER & GAMBLE COMPANY | 2011-08-11 | — | — | US | disclosed |
| WO-2011072002-A2 | A POROUS, DISSOLVABLE SOLID SUBSTRATE AND SURFACE RESIDENT COATING COMPRISING WATER SENSITIVE ACTIVES | THE PROCTER & GAMBLE COMPANY (US) | 2011-06-16 | — | — | WO | disclosed |
| WO-2011071965-A2 | POROUS, DISSOLVABLE SOLID SUBSTRATE AND SURFACE RESIDENT COATING COMPRISING A SKIN TREATMENT ACTIVE | THE GILLETTE COMPANY (US) | 2011-06-16 | — | — | WO | disclosed |
| US-20110132387-A1 | Porous, Dissolvable Solid Substrate And Surface Resident Coating Comprising A Skin Treatment Active | THE GILLETTE COMPANY | 2011-06-09 | — | — | US | disclosed |
| US-5495005-A | ANTICOAGULANTS, CARDIOVASCULAR DISORDERS | NATIONAL SCIENCE COUNCIL (TW) | 1996-02-27 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20110132387-A1 | Porous, Dissolvable Solid Substrate And Surface Resident Coating Comprising A Skin Treatment Active | CUTA, DSG1, CD44 | MAOA 779/4885KDM4E 352/4885CYP3A4 1711/4885 |
| US-20110200649-A1 | Porous, Dissolvable Solid Substrate And Surface Resident Coating Comprising A Zync Pyrithione | PORCN, CUTA, ZYX | MAOA 1432/4885KDM4E 652/4885CYP3A4 688/4885 |
| US-20110195098-A1 | Porous, Dissolvable Solid Substrate and Surface Resident Coating Comprising Water Sensitive Actives | CUTA, DSG1, SPG11 | MAOA 818/4885KDM4E 1583/4885CYP3A4 2936/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.